Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Lusher

Showing results (21-30 of 139) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|November 17, 1990
Lack of inhibitor to monoclonal-antibody purified factor VIII concentrateJ M Lusher
Bailliere'S Clinical Haematology|June 1, 1996
Recombinant clotting factor concentratesJ M Lusher
Annals of the New York Academy of Sciences|January 1, 1987
Factor VIII inhibitors. Etiology, characterization, natural history, and managementJ M Lusher
The New England Journal of Medicine|February 16, 1984
Myocardial necrosis after therapy with prothrombin-complex concentrateJ M Lusher
Seminars in Hematology|April 1, 1993
Prediction and management of adverse events associated with the use of factor IX complex concentratesJ M Lusher
Seminars in Hematology|April 1, 1994
Use of prothrombin complex concentrates in management of bleeding in hemophiliacs with inhibitors--benefits and limitationsJ M Lusher
Transfusion|October 1, 1993
Hemophilia: continued challenges but reason for optimism on many frontsJ M Lusher
Thrombosis and Haemostasis|July 1, 1997
Prophylaxis in children with hemophilia: is it the optimal treatment?J M Lusher
JAMA|August 9, 1985
Factor VIII concentrates: matching what you see with what you getJ M Lusher
Vox Sanguinis|October 26, 1999
Inhibitor development in prospective clinical trials with recombinant factor VIII preparations in previously untreated patientsJ M Lusher
Pageof 14

Showing results (21-30 of 139) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|November 17, 1990
Lack of inhibitor to monoclonal-antibody purified factor VIII concentrateJ M Lusher
Bailliere'S Clinical Haematology|June 1, 1996
Recombinant clotting factor concentratesJ M Lusher
Annals of the New York Academy of Sciences|January 1, 1987
Factor VIII inhibitors. Etiology, characterization, natural history, and managementJ M Lusher
The New England Journal of Medicine|February 16, 1984
Myocardial necrosis after therapy with prothrombin-complex concentrateJ M Lusher
Seminars in Hematology|April 1, 1993
Prediction and management of adverse events associated with the use of factor IX complex concentratesJ M Lusher
Seminars in Hematology|April 1, 1994
Use of prothrombin complex concentrates in management of bleeding in hemophiliacs with inhibitors--benefits and limitationsJ M Lusher
Transfusion|October 1, 1993
Hemophilia: continued challenges but reason for optimism on many frontsJ M Lusher
Thrombosis and Haemostasis|July 1, 1997
Prophylaxis in children with hemophilia: is it the optimal treatment?J M Lusher
JAMA|August 9, 1985
Factor VIII concentrates: matching what you see with what you getJ M Lusher
Vox Sanguinis|October 26, 1999
Inhibitor development in prospective clinical trials with recombinant factor VIII preparations in previously untreated patientsJ M Lusher
Pageof 14